Questioning Cancer Diagnoses

Millions Wrongly Treated for ‘Cancer,’ National Cancer Institute Panel Confirms

Wednesday, July 31st 2013 at 7:00 am

Written By:

Sayer Ji, Founder

Millions Wrongly Treated for 'Cancer,' National Cancer Institute Panel Confirms

A devastating new report commissioned by the National Cancer Institute reveals that our 40-year long ‘War on Cancer’ has been waged against a vastly misunderstood ‘enemy,’ that in many cases represented no threat to human health whatsoever.

If you have been following our advocacy work on cancer, particularly in connection with the dark side of breast cancer awareness month, you know that we have been calling for the complete reclassification of some types of ‘breast cancer’ as benign lesions, e.g. ductal carcinoma in situ (DCIS), as well as pointing out repeatedly that x-ray based breast screenings are not only highly carcinogenic but are also causing an epidemic of “overdiagnosis” and “overtreatment” in US women, with an estimated 1.3 million cases in the past 30 years alone.

This week, a National Cancer Institute commissioned panel’s report published in JAMA online confirmed that we all – public and professionals alike – should stop calling low-risk lesions like DCIS and high-grade prostatic intraepithelial neoplasia (HGPIN) ‘cancer.’

There are wide-reaching implications to this recommendation, including:

  • Millions of women in this country have been diagnosed with DCIS, and millions of men with HGPIN, and subsequently [mis]treated. Are they now to be retroactively reclassified as ‘victims’ of iatrogenesis, with legal recourse to seek compensation?
  • Anyone engaged in a cancer screening will now need to reconsider and weigh both the risks and benefits of such a ‘preventive’ strategy, considering that the likelihood of being diagnosed with a false positive over 10 years is already over 50% for women undergoing annual breast screening.
  • The burgeoning pink ribbon-bedecked ‘breast cancer awareness’ industry will be forced to reformulate its message, as it is theoretically culpable for the overdiagnosis and overtreatment of millions of US women by propagating an entirely false concept of ‘cancer.’

As reported by Medscape:

The practice of oncology in the United States is in need of a host of reforms and initiatives to mitigate the problem of overdiagnosis and overtreatment of cancer, according to a working group sanctioned by the National Cancer Institute.

Perhaps most dramatically, the group says that a number of premalignant conditions, including ductal carcinoma in situ and high-grade prostatic intraepithelial neoplasia, should no longer be called “cancer.”

Instead, the conditions should be labeled something more appropriate, such as indolent lesions of epithelial origin (IDLE), the working group suggests. The Viewpoint report was published online July 29 in JAMA.

Fundamentally, overdiagnosis results from the fact that screen-detected ‘cancers’ are disproportionately slower growing ones, present with few to no symptoms, and would never progress to cause harm if left undiagnosed and untreated.

As you can see by the graph above, it is the fast-growing tumors which will be more difficult to ‘detect early,’ and will progress rapidly enough to cause symptoms and perhaps even death unless treated aggressively. But even in the case of finding the tumor early enough to contain it through surgery, chemotherapy and/or radiation, it is well-known that the minority subpopulation of cancer stem cells within these tumors will be enriched and therefore made more malignant through conventional treatment. For instance, radiotherapy radiation wavelengths were only recently found by UCLA Jonnsson Comprehensive Cancer Center researchers to transform breast cancer cells into highly malignant cancer stem-cell like cells, with 30 times higher malignancy post-treatment.

hat this means is that not only are millions of screen-detected abnormalities not ‘cancer’ in the first place but even those which can be considered fast-growing are often being driven into greater malignancy by the conventional chemotherapy, radiation and surgery-based standard of cancer care itself.

Our entire world view of cancer needs to shift from an enemy that “attacks” us and that we must wage war against, to something our body does, presumably to survive an increasingly inhospitable, nutrient-deprived, carcinogen- and radiation-saturated environment, i.e. Cancer As An Ancient Survival Mechanism Unmasked.

When we look at cancer through the optic of fear and see it as an essentially chaos-driven infinitely expanding mass of cells, we are apt to make irrational choices. The physiological state of fear itself has been found to activate multidrug resistance proteins within cancer cells, explaining how our very perception of cancer can influence and/or determine its physiological status and/or trajectory within our body.

The NCI panel report opined:

“The word “cancer” often invokes the specter of an inexorably lethal process; however, cancers are heterogeneous and can follow multiple paths, not all of which progress to metastases and death, and include indolent disease that causes no harm during the patient’s lifetime.”

For more details on what our founder Sayer Ji calls the “Cancer Malignancy Meme,” see his video presentation at the Mind Body Week DC conference, wherein he discuss the ‘Rise of Biomedicine’ within the context of the mind-body connection, and breast cancer overdiagnosis in particular.

Sayer Ji, Mind Body Week D.C., Cancer Lecture

We must keep in mind that this proposed redefinition of cancer is no small academic matter, but will affect the lives of millions of women. Consider that every year, approximately 60,000 women in this country are diagnosed with DCIS, a diagnosis so traumatic that it results in significant psychiatric depression 3 years after even a ‘false positive’ diagnosis. For those less fortunate women, numbering in the millions over the past 30 years, who were told they had ‘cancer’ and needed to undergo lumpectomy, radiation, chemotherapy and/or mastectomy, the NCI panel’s recommendation is a hard pill swallow after the damage has already been irrevocably done.

So, what’s the solution? There is a growing movement towards the use of thermography as a primary diagnostic tool, as it uses no ionizing radiation, and can detect the underlying physiological processes that may indicate inflammation, angiogenesis, cancer-specific metabolic changes, etc., many years before a calcified lesion would appear within an x-ray mammogram. Also, the mainstay of any truly preventive strategy against cancer is diet, nutrition, exercise and avoiding chemical and radiation exposures – the things that we can do  in our daily lives to take back control of and responsibility for our health.

For related research read ‘Hidden Dangers’ of Mammograms Every Woman Should Know About

from:    http://www.greenmedinfo.com/blog/millions-wrongly-treated-cancer-national-cancer-institute-panel-confirms?page=2

On Mammograms

Some interesting studies are coming out on all levels and in all areas.   It is time to think twice about certain things, but do the research.

30 Years of Breast Screening: 1.3 Million Wrongly Treated

2nd December 2012

By Sayer Ji

Contributing writer for Wake Up World

The breast cancer industry’s holy grail (that mammography is the primary weapon in the war against breast cancer) has been disproved. In fact, mammography appears to have CREATED 1.3 million cases of breast cancer in the U.S. population that were not there.

A disturbing new study published in the New England Journal of Medicine is bringing mainstream attention to the possibility that mammography has caused far more harm than good in the millions of women who have employed it over the past 30 years as their primary strategy in the fight against breast cancer.[i]

Titled “Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence,” researchers estimated that among women younger than 40 years of age, breast cancer was overdiagnosed, i.e. “tumors were detected on screening that would never have led to clinical symptoms,” in 1.3 million U.S. women over the past 30 years. In 2008, alone, “breast cancer was overdiagnosed in more than 70,000 women; this accounted for 31% of all breast cancers diagnosed

As we revealed in a previous article,[ii] the primary form of mammography-detected breast cancer is ductal carcinoma in situ (DCIS), also known as ‘stage zero’ or ‘non-invasive breast cancer.’ Unlike truly invasive cancer, which expands outward like the crab after which it was named (Greek:  Cancer = Crab), ductal carcinoma is in situ, i.e. situated, non-moving – an obvious contradiction in terms.

Also, DCIS presents without symptoms in the majority of women within which it is detected, and if left untreated will (usually) not progress to cause harm to women. Indeed, without x-ray diagnostic technologies, many if not most of the women diagnosed with it would never have known they had it in the first place. The journal Lancet Oncology, in fact, published a cohort study last year finding that even clinically verified “invasive” cancers appear to regress with time if left untreated:

[We] believe many invasive breast cancers detected by repeated mammography screening do not persist to be detected by screening at the end of 6 years, suggesting that the natural course of many of the screen-detected invasive breast cancers is to spontaneously regress.[iii]

The new study authors point out “The introduction of screening mammography in the United States has been associated with a doubling in the number of cases of early-stage breast cancer that are detected each year.” And yet, they noted, only 6.5% of these early-stage breast cancer cases were expected to progress to advanced disease. DCIS and related ‘abnormal breast findings,’ in other words, may represent natural, benign variations in breast morphology. Preemptive treatment strategies, however, are still employed today as the standard of care, with mastectomy rates actually increasing since 2004.[iv]

The adverse health effects associated with overdiagnosis and overtreatment with lumpectomy, radiation, chemotherapy and hormone-suppressive treatments cannot be underestimated, especially when one considers the profound psychological trauma that follows each stage of diagnosis and treatment, and the additional physiological burdens such psychic injuries lead to, including up-regulation of multidrug resistance genes within cancer as a result of the increased adrenaline associated with the ‘flight-or-fight’ stress response.[v]

Also, it is now coming to light that chemotherapy and radiation actually increase the proportion of the highly malignant cancer stem cells to the relatively non-malignant daughter cells within the tumor colony. Much in the same way that conventional antibiotic agents will drive multidrug resistance within the subpopulation of surviving post-antibiotic bacteria, ensuring recurrence, conventional treatments also drive the surviving stem-cell enriched tumor populations into greater resistance and metastatic potential when it does inevitably recur. Or worse, radiation therapy may actually increase the ‘stemness’ of breast cancer cells making them 30 times more malignant (capable of forming new tumors).

If it is indeed true that DCIS, other abnormal breast findings, as well as clinically confirmed invasive breast cancer, either remain benign or regress when left untreated, the entire breast cancer industry, which is already deeply mired in cause-marketing conflicts of interest, must radically reform itself, or face massive financial and ethical liabilities vis-à-vis outdated and no longer “evidence-based” practices.

Another serious problem with mammography (and there are dozens of them) not addressed in this latest research finding concerns the unique carcinogenicity of the x-rays the technology employs. We now know that the 30 kVp radiation, colloquially known as “low energy” x-rays, are between 300-400% more carcinogenic than the “higher energy” radiation given off by atomic bomb blasts (200 kVp or higher).[vi] Present day radiation risk models used to assess the known breast cancer risk associated with mammography against the purported benefits do not take into this profound discrepancy. In fact, these models were developed before DNA was even discovered.

Also, considering that breast cancer susceptibility genes, BRCA1/BRCA2, interfere with the DNA self-repair mechanisms needed to reduce the carcinogenicity associated with radiation exposure within those who carry these genetic variations, the harms associated with mammography may be exponentially higher than the conventional medical community presently understands and communicates to their patients.  Indeed, it is likely that x-ray based mammography screenings have been planting the seeds of future radiation-induced breast cancer within exposed populations.

With top-tier biomedical journals now publishing research diametrically opposed to the policies and recommendations of both governmental, non-governmental and industry-sponsored health organizations, the time is ripe for us to critically evaluate conventional medicine’s conventional standard of care and to educate ourselves further to the true causes of cancer, and how to go about preventing and/or removing them.

from:    http://wakeup-world.com/2012/12/02/30-years-of-breast-screening-1-3-million-wrongly-treated/